Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Employer
- University of Helsinki
- UNIVERSITY OF HELSINKI
- University of Turku
- AALTO UNIVERSITY
- Itä-Suomen yliopisto
- Natural Resources Institute Finland (Luke)
- The Institute for Molecular Medicine Finland (FIMM) at University of Helsinki
- Åbo Akademi University
- Academic Europe
- Institute for Cardiogenetics, University of Lübeck
- VTT
- 1 more »
- « less
-
Field
-
Postdoctoral Researcher in Structural Biology of innate immune response in modulation of neuronal synapse loss in Alzheimer’s disease/neurodegeneration The HiLIFE - Institute of Biotechnology
-
Postdoctoral Researcher in Structural biology of innate immune response in modulation of neuronal synapse loss in Alzheimer’s disease/neurodegeneration The HiLIFE - Institute of Biotechnology
-
and National Institute for Health and Welfare. FIMM is part of the Nordic EMBL Partnership for Molecular Medicine, composed of the European Molecular Biology Laboratory (EMBL) and the centres
-
staff position within a Research Infrastructure? No Offer Description Postdoctoral Researcher in parasitology/structural biology The HiLIFE - Institute of Biotechnology at the University of Helsinki
-
Postdoctoral Researcher in parasitology/structural biology The HiLIFE - Institute of Biotechnology at the University of Helsinki, renowned for its international research excellence, is excited
-
and National Institute for Health and Welfare. FIMM is part of the Nordic EMBL Partnership for Molecular Medicine, composed of the European Molecular Biology Laboratory (EMBL) and the centres
-
European Molecular Biology Laboratory (EMBL) , with complementary research expertise at the forefront of molecular medicine research. With the NORPOD program, the Nordic EMBL Partnership aims to foster
-
-throughput omics, molecular biology, drug library screens, characterization of the patient cohorts and the functional studies in experimental models. This is a new and exciting research field, with the goals
-
-throughput omics, molecular biology, drug library screens, characterization of the patient cohorts and the functional studies in experimental models. This is a new and exciting research field, with the goals
-
provided in Rafa Najumudeen’s lab (http://najumudeenlab.com), located at Institute of Biotechnology, University of Helsinki, Finland. The lab is part of Institute of Molecular Medicine (FIMM) and Helsinki